UBS Group Upgrades Fresenius Medical Care AG & Co. (FMS) to Neutral

Fresenius Medical Care AG & Co. (NYSE:FMS) was upgraded by equities research analysts at UBS Group from a “sell” rating to a “neutral” rating in a research note issued on Thursday.

Other research analysts have also issued research reports about the stock. Royal Bank of Canada restated a “hold” rating and set a $44.00 price target on shares of Fresenius Medical Care AG & Co. in a research note on Wednesday, September 13th. Nord/LB restated a “buy” rating on shares of Fresenius Medical Care AG & Co. in a research note on Tuesday. SunTrust Banks set a $62.00 price target on shares of Fresenius Medical Care AG & Co. and gave the stock a “buy” rating in a research note on Thursday, December 21st. DZ Bank restated a “buy” rating on shares of Fresenius Medical Care AG & Co. in a research note on Monday, November 13th. Finally, Morgan Stanley lowered shares of Fresenius Medical Care AG & Co. from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 11th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $53.00.

Shares of Fresenius Medical Care AG & Co. (FMS) traded up $0.30 on Thursday, hitting $52.64. 83,100 shares of the stock traded hands, compared to its average volume of 101,350. Fresenius Medical Care AG & Co. has a 52 week low of $39.46 and a 52 week high of $52.96. The firm has a market cap of $32,141.47, a price-to-earnings ratio of 23.61, a price-to-earnings-growth ratio of 2.18 and a beta of 0.45. The company has a current ratio of 1.22, a quick ratio of 0.98 and a debt-to-equity ratio of 0.55.

Several institutional investors and hedge funds have recently made changes to their positions in the company. UBS Asset Management Americas Inc. boosted its holdings in shares of Fresenius Medical Care AG & Co. by 3.6% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 2,357 shares of the company’s stock worth $114,000 after buying an additional 81 shares during the period. Pacer Advisors Inc. bought a new stake in shares of Fresenius Medical Care AG & Co. during the 2nd quarter worth $179,000. HPM Partners LLC bought a new stake in shares of Fresenius Medical Care AG & Co. during the 2nd quarter worth $221,000. YorkBridge Wealth Partners LLC boosted its holdings in shares of Fresenius Medical Care AG & Co. by 19.4% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 4,613 shares of the company’s stock worth $222,000 after buying an additional 749 shares during the period. Finally, Stifel Financial Corp bought a new stake in shares of Fresenius Medical Care AG & Co. during the 2nd quarter worth $225,000. Institutional investors own 3.02% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “UBS Group Upgrades Fresenius Medical Care AG & Co. (FMS) to Neutral” was first posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://transcriptdaily.com/2018/01/04/ubs-group-upgrades-fresenius-medical-care-ag-co-fms-to-neutral.html.

Fresenius Medical Care AG & Co. Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Analyst Recommendations for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply